Literature DB >> 24841324

Supramolecular inhibition of amyloid fibrillation by cucurbit[7]uril.

Hong Hee Lee1, Tae Su Choi, Shin Jung C Lee, Jong Wha Lee, Junghong Park, Young Ho Ko, Won Jong Kim, Kimoon Kim, Hugh I Kim.   

Abstract

Amyloid fibrils are insoluble protein aggregates comprised of highly ordered β-sheet structures and they are involved in the pathology of amyloidoses, such as Alzheimer's disease. A supramolecular strategy is presented for inhibiting amyloid fibrillation by using cucurbit[7]uril (CB[7]). CB[7] prevents the fibrillation of insulin and β-amyloid by capturing phenylalanine (Phe) residues, which are crucial to the hydrophobic interactions formed during amyloid fibrillation. These results suggest that the Phe-specific binding of CB[7] can modulate the intermolecular interaction of amyloid proteins and prevent the transition from monomeric to multimeric states. CB[7] thus has potential for the development of a therapeutic strategy for amyloidosis.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  aggregation; cucurbit[7]uril; insulin; supramolecular chemistry; β-amyloid

Mesh:

Substances:

Year:  2014        PMID: 24841324     DOI: 10.1002/anie.201402496

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  23 in total

1.  Supramolecular Inhibition of Neurodegeneration by a Synthetic Receptor.

Authors:  Shengke Li; Huanxian Chen; Xue Yang; David Bardelang; Ian W Wyman; Jianbo Wan; Simon M Y Lee; Ruibing Wang
Journal:  ACS Med Chem Lett       Date:  2015-10-16       Impact factor: 4.345

2.  Cationic acyclic cucurbit[n]uril-type containers: synthesis and molecular recognition toward nucleotides.

Authors:  David Sigwalt; Peter Y Zavalij; Lyle Isaacs
Journal:  Supramol Chem       Date:  2016-04-13       Impact factor: 1.688

3.  Amyloid fibrillation of insulin under water-limited conditions.

Authors:  Tae Su Choi; Jong Wha Lee; Kyeong Sik Jin; Hugh I Kim
Journal:  Biophys J       Date:  2014-10-21       Impact factor: 4.033

4.  Opposing Effects of Cucurbit[7]uril and 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranose on Amyloid β25-35 Assembly.

Authors:  Natália E C de Almeida; Thanh D Do; Michael Tro; Nichole E LaPointe; Stuart C Feinstein; Joan-Emma Shea; Michael T Bowers
Journal:  ACS Chem Neurosci       Date:  2015-12-10       Impact factor: 5.780

5.  Amyloid β-protein assembly: The effect of molecular tweezers CLR01 and CLR03.

Authors:  Xueyun Zheng; Deyu Liu; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Michael T Bowers
Journal:  J Phys Chem B       Date:  2015-03-16       Impact factor: 2.991

6.  A Small Molecule Impedes Insulin Fibrillation: Another New Role of Phenothiazine Derivatives.

Authors:  Meghomukta Mukherjee; Jagannath Jana; Subhrangsu Chatterjee
Journal:  ChemistryOpen       Date:  2017-12-07       Impact factor: 2.911

7.  In Vitro selectivity of an acyclic cucurbit[n]uril molecular container towards neuromuscular blocking agents relative to commonly used drugs.

Authors:  Shweta Ganapati; Peter Y Zavalij; Matthias Eikermann; Lyle Isaacs
Journal:  Org Biomol Chem       Date:  2015-12-09       Impact factor: 3.876

8.  Prion-derived tetrapeptide stabilizes thermolabile insulin via conformational trapping.

Authors:  Meghomukta Mukherjee; Debajyoti Das; Jit Sarkar; Nilanjan Banerjee; Jagannath Jana; Jyotsna Bhat; Jithender Reddy G; Jagadeesh Bharatam; Samit Chattopadhyay; Subhrangsu Chatterjee; Partha Chakrabarti
Journal:  iScience       Date:  2021-05-21

9.  Inhibition of Beta-Amyloid Fibrillation by Luminescent Iridium(III) Complex Probes.

Authors:  Lihua Lu; Hai-Jing Zhong; Modi Wang; See-Lok Ho; Hung-Wing Li; Chung-Hang Leung; Dik-Lung Ma
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

10.  Nanoscale Control of Amyloid Self-Assembly Using Protein Phase Transfer by Host-Guest Chemistry.

Authors:  Tae Su Choi; Hong Hee Lee; Young Ho Ko; Kwang Seob Jeong; Kimoon Kim; Hugh I Kim
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.